1. Home
  2. Browse
  3. Cardiology
  4. Antithrombotics
  5. Treatment
  6. Prasugrel (Effient)

Prasugrel (Effient)

46 - 60 of 60 Results
Sort Results:
Guideline: 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention June 2010
Guideline: Prevention of Premature Discontinuation of Antiplatelet Therapy in Patients with Coronary Stents June 2010
Commentary: Antiplatelet Therapy for Coronary Stents June 2010
Guideline: ACC/AHA Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction June 2010
Article: how long patients should take aspirin PLUS clopidogrel (Plavix) OR prasugrel (Effient) after a coronary stent June 2010
Article: whether patients should get genetic tests to help determine dosing for warfarin or clopidogrel (Plavix) May 2010
Article: a specific list of drugs to avoid with Plavix January 2010
Article: whether proton pump inhibitors decrease the efficacy of clopidogrel (Plavix) November 2009
Article: triple antithrombotic therapy with warfarin, aspirin, AND clopidogrel (Plavix) September 2009
Guideline: Primary and Secondary Prevention of Coronary Artery Disease (ACCP, 8th edition) September 2009
Guideline: Percutaneous Coronary Intervention (ACC/AHA/SCAI, 2007 Update) September 2009
Article: Effient (EF-fee-ent, prasugrel), a new oral antiplatelet drug for patients getting angioplasty August 2009
Article: proton pump inhibitors (PPIs) might DECREASE the efficacy of clopidogrel (Plavix) April 2009
Guideline: Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use April 2009
Article: Clopidogrel (Plavix) will compete with prasugrel (Effient) April 2008